41 filings
Page 2 of 3
8-K
y9loudxuq7 nki
2 Nov 22
Other Events
6:07am
8-K
fdgxylyr
27 Oct 22
Entry into a Material Definitive Agreement
4:06pm
8-K
k23qr nx5rfcbq2ua
21 Oct 22
Other Events
7:36am
8-K
jhpzsczsc 5dx
30 Sep 22
Entry into a Material Definitive Agreement
4:07pm
8-K
g98tpytm76m s6acpx1
2 Sep 22
Departure of Directors or Certain Officers
4:05pm
8-K
3hu0e7xbkwjedwi1w
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
8-K
xs9wua5urj 6enp3nxh
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
y7fjnhb
12 May 22
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
4:11pm
8-K
dcypm
6 May 22
Termination of a Material Definitive Agreement
4:06pm
8-K
83earll0y3i
31 Mar 22
Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
12:00am
8-K
1yl2uiou
17 Mar 22
Departure of Directors or Certain Officers
4:05pm
8-K
r783tbw8snearfd
10 Nov 21
Silverback Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
4:20pm
8-K
cepwj8g75
16 Sep 21
Regulation FD Disclosure
7:37am
8-K
05hhlmr7wtax0ock5c4
13 Sep 21
Regulation FD Disclosure
8:06am
8-K
cpmbaz ndajlj5
12 Aug 21
Silverback Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
4:16pm
8-K
3wbhw3ehmumqis 9n
2 Jul 21
Entry into a Material Definitive Agreement
4:06pm
8-K
ehwv5ew92b
9 Jun 21
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
bjymxy1 fqbo7zl4v
13 May 21
Silverback Therapeutics Reports First Quarter 2021 Financial Results
4:17pm
8-K
3le8t1
29 Mar 21
Silverback Therapeutics Reports Fourth Quarter and Full Year 2020
4:11pm
8-K
zwbwjxlou
15 Mar 21
Silverback Therapeutics Announces the Appointment of Dr. Maria Koehler to its Board of Directors
4:05pm